Skip to main content

Advertisement

SpringerLink
Log in

Update on Sleep and Pulmonary Comorbidities in Psoriasis

  • Psoriasis (J Wu, Section Editor)
  • Published:
Current Dermatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The purpose of this review article is to provide an overview of sleep and pulmonary comorbidities in patients with psoriasis and summarize important recent findings.

Recent Findings

Evidence continues to show that patients with psoriasis experience greater chronic sleep impairment when compared to healthy counterparts. In addition to other comorbidities seen in psoriasis patients, including cardiovascular disease, obesity, and diabetes, obstructive sleep apnea and chronic obstructive pulmonary disease have increased frequency in this population.

Summary

Sleep and pulmonary comorbidities in psoriasis contribute to disease burden and impaired quality of life in psoriasis patients. The evaluation of sleep comorbidities is complicated by the overlap with other comorbidities such as depression and anxiety. Regardless, there is strong evidence to indicate an elevated prevalence of insomnia in psoriasis patients. A causal relationship between psoriasis and insomnia has yet to be determined. There is moderate evidence to suggest increased risk of developing OSA in psoriasis patients, even when accounting for increased BMI. Most studies on sleep impairment in psoriasis patients have used self-reported data, of which only a portion has been validated. As such, there is a need to better evaluate sleep dysfunction in psoriasis patients. Regarding pulmonary comorbidities, psoriasis patients are more likely to smoke compared to the general population, which complicates evaluation of risk of COPD, lung cancer, and pulmonary infections in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512–6.

    Article  Google Scholar 

  2. Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80(4):1073–113.

    Article  Google Scholar 

  3. Lorton D, Lubahn CL, Estus C, Millar BA, Carter JL, Wood CA, et al. Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep. Neuroimmunomodulation. 2006;13(5–6):357–74.

    Article  CAS  Google Scholar 

  4. Besedovsky L, Lange T, Haack M. The sleep-immune crosstalk in health and disease. Physiol Rev. 2019;99(3):1325–80.

    Article  Google Scholar 

  5. Bjurström MF, Olmstead R, Irwin MR. Reciprocal relationship between sleep macrostructure and evening and morning cellular inflammation in rheumatoid arthritis. Psychosom Med. 2017;79(1):24–33.

    Article  Google Scholar 

  6. Okamoto-Mizuno K, Mizuno K. Effects of thermal environment on sleep and circadian rhythm. J Physiol Anthropol. 2012;31(1):14.

    Article  Google Scholar 

  7. Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: a systematic review. Sleep Med Rev. 2016;29:63–75.

    Article  Google Scholar 

  8. Henry AL, Kyle SD, Bhandari S, Chisholm A, Griffiths CEM, Bundy C. Measurement, classification and evaluation of sleep disturbance in psoriasis: a systematic review. PLoS ONE. 2016;11:e0157843 Systematic review of 32 studies evaluating sleep disturbance in psoriasis that discusses quality of studies and utilization of objective sleep evaluation measures.

    Article  Google Scholar 

  9. Henry AL, Kyle SD, Chisholm A, Griffiths CEM, Bundy C. A cross-sectional survey of the nature and correlates of sleep disturbance in people with psoriasis. Br J Dermatol. 2017;177(4):1052–9.

    Article  CAS  Google Scholar 

  10. Jensen P, Zachariae C, Skov L, Zachariae R. Sleep disturbance in psoriasis: a case-controlled study. Br J Dermatol. 2018;179(6):1376–84.

    Article  CAS  Google Scholar 

  11. Stull C, Grossman S, Yosipovitch G. Current and emerging therapies for itch management in psoriasis. Am J Clin Dermatol. 2016;17(6):617–24.

    Article  Google Scholar 

  12. Smith MP, Ly K, Thibodeaux Q, Weerasinghe T, Wu JJ, Yosipovitch G, et al. Emerging methods to objectively assess pruritus in atopic dermatitis. Dermatol Ther. 2019;9(3):407–20.

    Article  Google Scholar 

  13. Buysse DJ. Insomnia. JAMA. 2013;309(7):706–16.

    Article  CAS  Google Scholar 

  14. Smith MP, Ly K, Thibodeaux Q, Weerasinghe T, Beck K, Shankle L, et al. Factors influencing sleep difficulty and sleep quantity in the citizen pscientist psoriatic cohort. Dermatol Ther. 2019;9(3):511–23.

    Article  Google Scholar 

  15. Strober BE, Sobell JM, Duffin KC, Bao Y, Guérin A, Yang H, et al. Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label phase IIIB trial. Br J Dermatol. 2012;167(6):1374–81.

    Article  CAS  Google Scholar 

  16. Thaçi D, Galimberti R, Amaya-Guerra M, Rosenbach T, Robertson D, Pedersen R, et al. Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial. J Eur Acad Dermatol Venereol. 2014;28(7):900–6.

    Article  Google Scholar 

  17. Lee W, Nagubadi S, Kryger MH, Mokhlesi B. Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Rev Respir Med. 2008;2(3):349–64.

    Article  Google Scholar 

  18. Papadavid E, Dalamaga M, Vlami K, Koumaki D, Gyftopoulos S, Christodoulatos GS, et al. Psoriasis is associated with risk of obstructive sleep apnea independently from metabolic parameters and other comorbidities: a large hospital-based case-control study. Sleep Breath. 2017;21(4):949–58.

    Article  Google Scholar 

  19. Maari C, Bolduc C, Nigen S, Marchessault P, Bissonnette R. Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial. J Dermatol Treat. 2014 Feb 1;25(1):57–60.

    Article  CAS  Google Scholar 

  20. Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR. Psoriasis and sleep apnea: a danish nationwide cohort study. J Clin Sleep Med. 2016;12(5):663–71 Large nationwide prospective cohort study that analyzed incidence of developing OSA in psoriasis patients (and vice versa) while controlling for major confounders.

    Article  Google Scholar 

  21. Yang Y-W, Kang J-H, Lin H-C. Increased risk of psoriasis following obstructive sleep apnea: a longitudinal population-based study. Sleep Med. 2012;13(3):285–9.

    Article  Google Scholar 

  22. Martínez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, Andrés CD, Fernández-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res. 2014;23(4):414–9.

    Article  Google Scholar 

  23. van Durme YMTA, Verhamme KMC, Stijnen T, van Rooij FJA, Van Pottelberge GR, Hofman A, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest. 2009;135(2):368–77.

    Article  Google Scholar 

  24. Richer V, Roubille C, Fleming P, Starnino T, McCourt C, McFarlane A, et al. Psoriasis and smoking: a systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity. J Cutan Med Surg. 2016;20(3):221–7.

    Article  Google Scholar 

  25. Semenov YR, Herbosa CM, Rogers AT, et al. Psoriasis and mortality in the US: data from the national health and nutrition examination survey. J Am Acad Dermatol. 2019;S0190-9622(19)32558–7.

  26. Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol. 2014;170(2):304–14.

    Article  CAS  Google Scholar 

  27. Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149(10):1173–9.

    Article  Google Scholar 

  28. Li X, Kong L, Li F, Chen C, Xu R, Wang H, et al. Association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One. 2015;10(12):e0145221.

    Article  Google Scholar 

  29. Ungprasert P, Srivali N, Thongprayoon C. Association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Dermatol Treat. 2016;27(4):316–21.

    Article  Google Scholar 

  30. Dreiher J, Weitzman D, Shapiro J, Davidovici B, Cohen AD. Psoriasis and chronic obstructive pulmonary disease: a case–control study. Br J Dermatol. 2008 Oct 1;159(4):956–60.

    Article  CAS  Google Scholar 

  31. Wu C-Y, Hu H-Y, Li C-P, Chou Y-J, Chang Y-T. Comorbidity profiles of psoriasis in Taiwan: a latent class analysis. PLoS One. 2018;13(2):e0192537.

    Article  Google Scholar 

  32. Sbidian E, Giboin C, Bachelez H, Paul C, Beylot-Barry M, Dupuy A, et al. Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort. J Eur Acad Dermatol Venereol. 2017;31(12):2046–54.

    Article  CAS  Google Scholar 

  33. Lee JH, Kim HJ, Han KD, Kim H-N, Park YM, Lee JY, et al. Cancer risk in 892 089 patients with psoriasis in Korea: a nationwide population-based cohort study. J Dermatol. 2019;46(2):95–102.

    Article  Google Scholar 

  34. Fuxench ZCC, Shin DB, Beatty AO, Gelfand JM. The risk of cancer in patients with psoriasis: a population-based cohort study in the health improvement network. JAMA Dermatol. 2016;152(3):282–90.

    Article  Google Scholar 

  35. Moyer VA. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;160(5):330–8.

    Article  Google Scholar 

  36. Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377–90.

    Article  Google Scholar 

  37. Kalb RE, Fiorentino DF, Lebwohl MG, Toole J, Poulin Y, Cohen AD, et al. Risk of serious infection with biologic and systemic treatment of psoriasis: results from the psoriasis longitudinal assessment and registry (PSOLAR). JAMA Dermatol. 2015;151(9):961–9.

    Article  Google Scholar 

  38. Kao L-T, Lee C-Z, Liu S-P, Tsai M-C, Lin H-C. Psoriasis and the risk of pneumonia: a population-based study. PLoS ONE. 2014;9:e116077.

    Article  Google Scholar 

  39. Dommasch ED, Kim SC, Lee MP, Gagne JJ. Risk of serious infection in patients receiving systemic medications for the treatment of psoriasis. JAMA Dermatol. Published online. 2019. https://doi.org/10.1001/jamadermatol.2019.1121.

  40. Papp KK, Penrod CE, Strohl KP. Knowledge and attitudes of primary care physicians toward sleep and sleep disorders. Sleep Breath. 2002;6(3):103–9.

    Article  Google Scholar 

Download references

Funding

Dr. Wilson Liao has received research grant funding from Abbvie, Amgen, Janssen, Novartis, Regeneron, Sanofi, and TRex Bio

Author information

Authors and Affiliations

  1. Department of Dermatology, University of California, 515 Spruce Street, San Francisco, CA, 94118, USA

    V. Reddy, B. Myers, N. Brownstone, Q. Thibodeaux, S. Chan, W. Liao & T. Bhutani

Authors
  1. V. Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Myers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Brownstone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Q. Thibodeaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Bhutani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Reddy.

Ethics declarations

Conflict of Interest

Dr. Tina Bhutani is a PI for Janssen, Merck, Celgene, and Regeneron and an advisor for Abbvie and Eli Lilly. Drs. Reddy, Myers, Brownstone, Thibodeaux, and Chan declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Psoriasis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reddy, V., Myers, B., Brownstone, N. et al. Update on Sleep and Pulmonary Comorbidities in Psoriasis. Curr Derm Rep 9, 30–35 (2020). https://doi.org/10.1007/s13671-020-00293-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13671-020-00293-3

Keywords

Search

Navigation